Related Experiment Video
Updated: Aug 29, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Protein kinase C modulates negatively the hepatocyte growth factor-induced migration, integrin expression and
Annamária Gujdár1, Szabolcs Sipeki, Erzsébet Bander
1Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, P.O. Box 260, 1444, Budapest, Hungary.
Abstract:
Previously, we reported that, in hepatocyte growth factor (HGF)-induced HepG2 cells, protein kinase C (PKC) decreased the duration of intensive Erk1/Erk2 MAP kinase activation. This study shows that the inhibition of PKC enhanced significantly the HGF-induced integrin expression. Beside the prolonged activation of Erk1/Erk2, the activity of phosphatidylinositol 3-kinase (PI 3K) was required for growth factor-induced integrin expression. PI 3-kinase was activated to a higher extent in response to HGF than to epidermal growth factor (EGF), though the activation was transient in both cases. In EGF-induced cells, PI 3K activation was terminated by the loss of phosphotyrosine docking sites for PI 3K. To the contrary, the decrease of PI 3K activation, which followed the HGF-induced increase was not accompanied by the loss of phosphotyrosine docking sites and was prevented by the inhibition of PKC. The negative modulator effects of PKC on integrin expression and PI 3-kinase activation correlated with its ability to limit the HGF-induced motogen response.
Insights
Protein kinase C (PKC) negatively regulates hepatocyte growth factor (HGF)-induced integrin expression by limiting Erk1/Erk2 and phosphatidylinositol 3-kinase (PI 3K) activation. Inhibiting PKC enhances integrin expression and prolongs MAP kinase activation.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- Protein kinase C (PKC) was previously shown to decrease the duration of Erk1/Erk2 MAP kinase activation in hepatocyte growth factor (HGF)-induced HepG2 cells.
- Integrin expression plays a crucial role in cell adhesion and migration, processes often dysregulated in disease.
Purpose of the Study:
- To investigate the role of PKC in regulating HGF-induced integrin expression.
- To elucidate the signaling pathways, including Erk1/Erk2 and phosphatidylinositol 3-kinase (PI 3K), involved in HGF-induced integrin expression.
Main Methods:
- Utilized HepG2 cells stimulated with HGF and epidermal growth factor (EGF).
- Assessed integrin expression levels.
- Measured the activation of Erk1/Erk2 MAP kinase and PI 3K.
- Employed PKC inhibition as a key experimental manipulation.
Main Results:
- Inhibition of PKC significantly enhanced HGF-induced integrin expression.
- Prolonged activation of Erk1/Erk2 was observed alongside enhanced integrin expression.
- PI 3K activity was essential for growth factor-induced integrin expression.
- PKC inhibition prevented the decrease in PI 3K activation following HGF stimulation, unlike in EGF-stimulated cells.
Conclusions:
- PKC acts as a negative modulator of HGF-induced integrin expression.
- The findings highlight a crosstalk between PKC, Erk1/Erk2, and PI 3K signaling in regulating integrin expression.
- PKC's modulation of these pathways influences the HGF-induced mitogenic response.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
